Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rikke V. Grônlund"'
Autor:
Henrik H. Hansen, Rikke V. Grønlund, Tamara Baader-Pagler, Peter Haebel, Harald Tammen, Leif Kongskov Larsen, Jacob Jelsing, Niels Vrang, Thomas Klein
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Dipeptidyl peptidase IV (DPP-IV) inhibitors improve glycemic control by prolonging the action of glucagon-like peptide-1 (GLP-1). In contrast to GLP-1 analogues, DPP-IV inhibitors are weight-neutral. DPP-IV cleavage of PYY and NPY gives rise
Externí odkaz:
https://doaj.org/article/97a3ac05b965484c814efcbeef1dbf0b
Autor:
Leif K. Larsen, Henrik H. Hansen, Jacob Jelsing, Harald Tammen, Niels Vrang, Peter W. Haebel, Rikke V. Grônlund, Thomas Klein, Tamara Baader-Pagler
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Dipeptidyl peptidase IV (DPP-IV) inhibitors improve glycemic control by prolonging the action of glucagon-like peptide-1 (GLP-1). In contrast to GLP-1 analogues, DPP-IV inhibitors are weight-neutral. DPP-IV cleavage of PYY and NPY gives rise to PYY3-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::120fa05ea99ec2378256ffe043c674e3
https://pubmed.ncbi.nlm.nih.gov/33850212
https://pubmed.ncbi.nlm.nih.gov/33850212
Autor:
James L. Trevaskis, Brandon B. Boland, Gitte Hansen, Joseph Grimsby, Michael Sulikowski, Jennifer Cann, Rikke V. Grônlund, Wanda King, Christopher J. Rhodes, Cristina M. Rondinone, Michelle L. Boland, Charles Brown
Publikováno v:
Diabetes. 68:131-140
The onset of common obesity-linked type 2 diabetes (T2D) is marked by exhaustive failure of pancreatic β-cell functional mass to compensate for insulin resistance and increased metabolic demand, leading to uncontrolled hyperglycemia. Here, the β-ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8f2f7b8f33f2297e63a1f4cfe049d2d
https://doi.org/10.2337/db18-0304
https://doi.org/10.2337/db18-0304
Publikováno v:
Diabetes. 67
MEDI0382 is a potent GLP-1 and glucagon receptor dual agonist peptide that decreases body weight of obese mice by reducing food intake and enhancing energy expenditure. Here we explored whether MEDI0382 may, in part, mediate its effects on metabolism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e62cae7aa52bce016230cd336e15911
https://doi.org/10.2337/db18-1788-p
https://doi.org/10.2337/db18-1788-p